XW-LTH-03

N/A

Report date: 2026/01/23 20:01:08

Base Information

Drug NameXW-LTH-03
Drug Alias NameHypoxia-Inducible CD73/AXL-Targeting CAR-T Cells therapy (SINOBAY)XW-LTH-03
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of Action5'-nucleotidase modulatorsT lymphocyte replacements
Targets5'-nucleotidase
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai SinoBay Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai SinoBay Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A